Psychedelic drugs for treatment of mental illness focus of U of C research chair
Red Deer AdvocateJun 10, 2021
It's believed to be the first of its kind in
A
He says she received five rounds of intravenous ketamine therapy, precisely dosed under medical supervision.
The field of psychedelic research for mental health is attracting growing interest from the scientific and medical communities.
Ketamine, MDMA (ecstasy) and psilocybin, commonly known as magic mushrooms, have the potential to treat depression, anxiety, post-traumatic stress disorder and addiction.